ArticleCME ARTICLE Oxymorphone and Its New Extended- and Immediate-Release Formulations A Critical ReviewGevirtz, Clifford MD, MPHAuthor Information Dr. Gevirtz is Associate Professor of Anesthesiology, Louisiana State University Health Center, New Orleans, and Medical Director, Somnia Pain Management, 627 West Street, Harrison, NY 10528; E-mail: [email protected]. All faculty and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity. Lippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation assessment survey on the enclosed form, answering at least 70% of the quiz questions correctly. This activity expires on February 29, 2012. Topics in Pain Management: March 2011 - Volume 26 - Issue 8 - p 1-7 doi: 10.1097/01.TPM.0000395316.11432.ba Buy CME Test Metrics Copyright © 2011 Wolters Kluwer Health, Inc. All rights reserved.